Forus Raises $150M at $3B Valuation to Automate Healthcare's Prescription-to-Treatment Workflow

San Francisco, September 8, 2026. Forus, a blockchain infrastructure protocol targeting healthcare operational workflows, has closed a $150 million funding round at a $3 billion post-money valuation. The raise positions Forus to deploy decentralized automation across the prescription-to-treatment pipeline, a workflow segment responsible for an estimated $290 billion in annual inefficiency costs across the US healthcare system.

The funding arrives as approximately 70% of US pharmacies continue operating on legacy systems lacking modern interoperability, and insurance prior authorizations average two to three days per prescription. Forus is building protocol infrastructure to compress those timelines through smart contract automation, cryptographic verification, and decentralized coordination between providers, pharmacies, and insurers.

The protocol targets three specific workflow bottlenecks: insurance prior authorization, which currently requires manual back-and-forth averaging 48 to 72 hours per case; prescription routing between providers and dispensing pharmacies; and medication adherence tracking across fragmented care settings. Forus uses smart contracts to automate authorization logic against insurer rule sets, reducing manual administrative overhead while maintaining an immutable audit trail for regulatory compliance. The architecture separates sensitive patient data from on-chain execution, addressing HIPAA requirements through cryptographic commitments and off-chain storage with on-chain verification.

The $4.8 trillion US healthcare market represents the total addressable context for the company's infrastructure play, though Forus is targeting a specific operational layer rather than the full market. The company's enterprise value proposition centers on quantifiable cost reduction for pharmacy chains, hospital systems, and pharmacy benefit managers.

Forus has outlined a deployment roadmap targeting mainnet launch in Q4 2026, followed by initial enterprise pilot programs with pharmacy chains in Q1 2027. The company is pursuing integration with major electronic health record platforms including Epic and Cerner, which collectively hold more than 60% of the US hospital EHR market. Insurance company partnerships enabling real-time authorization through the Forus protocol are targeted for mid-2027, with published case studies quantifying prescription processing time reductions expected by Q3 2027.

Regulatory engagement is a stated priority. Forus is working with healthcare regulatory specialists to align its architecture with existing FDA drug distribution guidance and HHS HIPAA enforcement frameworks. The 21st Century Cures Act's interoperability mandates create structural regulatory pressure on healthcare systems to adopt solutions capable of cross-platform data exchange, a requirement Forus's decentralized architecture is designed to satisfy.

The current round is structured as equity financing. The company has not disclosed token launch timing or economics.

About Forus

Forus is a healthcare blockchain infrastructure company building decentralized automation for the prescription-to-treatment workflow. The protocol targets operational inefficiencies between providers, pharmacies, and insurers through smart contract automation, cryptographic verification, and interoperable data coordination. Forus is headquartered in San Francisco and is backed by institutional investors focused on healthcare technology and blockchain infrastructure. Additional information is available at forus.io.

This press release contains forward-looking statements based on current expectations and projections. Actual results may differ materially from those described. Forus undertakes no obligation to update forward-looking statements following publication.